Ind-Swift Limited (INDSWFTLTD.NS)
INR 13.18
(1.38%)
INR 13.18
(1.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 10.09 Billion INR | 150.43% |
| 2022 | 4.03 Billion INR | -33.4% |
| 2021 | 6.05 Billion INR | -3.94% |
| 2020 | 6.3 Billion INR | -0.01% |
| 2019 | 6.3 Billion INR | -0.04% |
| 2018 | 6.3 Billion INR | -5.48% |
| 2017 | 6.66 Billion INR | 0.34% |
| 2016 | 6.64 Billion INR | -1.02% |
| 2015 | 6.71 Billion INR | 24.06% |
| 2014 | 5.41 Billion INR | -7.47% |
| 2013 | 5.85 Billion INR | -0.94% |
| 2012 | 5.9 Billion INR | 116.67% |
| 2011 | 2.72 Billion INR | -54.48% |
| 2010 | 5.98 Billion INR | 15.38% |
| 2009 | 5.18 Billion INR | 34.52% |
| 2008 | 3.85 Billion INR | -1.56% |
| 2007 | 3.91 Billion INR | 29.64% |
| 2006 | 3.02 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 10.09 Billion INR | 150.43% |
| 2023 Q4 | 10.09 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 4.08 Billion INR | 0.0% |
| 2022 Q2 | 6.22 Billion INR | 0.0% |
| 2022 Q4 | 4.03 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 4.03 Billion INR | -33.4% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 6.05 Billion INR | -3.94% |
| 2021 Q4 | 6.05 Billion INR | 0.0% |
| 2021 Q2 | 6.28 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 6.3 Billion INR | 0.0% |
| 2020 FY | 6.3 Billion INR | -0.01% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 6.43 Billion INR | 0.0% |
| 2019 FY | 6.3 Billion INR | -0.04% |
| 2019 Q2 | 6.36 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 6.3 Billion INR | 0.0% |
| 2018 Q4 | 6.3 Billion INR | 0.0% |
| 2018 FY | 6.3 Billion INR | -5.48% |
| 2018 Q1 | - INR | -100.0% |
| 2017 FY | 6.66 Billion INR | 0.34% |
| 2017 Q4 | 6.66 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 6.64 Billion INR | 0.0% |
| 2016 FY | 6.64 Billion INR | -1.02% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 6.66 Billion INR | 0.0% |
| 2015 Q2 | 4.96 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 6.71 Billion INR | 0.0% |
| 2015 FY | 6.71 Billion INR | 24.06% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 5.41 Billion INR | -7.47% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 5.41 Billion INR | 0.0% |
| 2014 Q2 | 5.77 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q4 | 5.85 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 6.12 Billion INR | 0.0% |
| 2013 FY | 5.85 Billion INR | -0.94% |
| 2012 Q4 | 5.9 Billion INR | -45.28% |
| 2012 Q3 | 10.79 Billion INR | 0.0% |
| 2012 FY | 5.9 Billion INR | 116.67% |
| 2011 FY | 2.72 Billion INR | -54.48% |
| 2010 FY | 5.98 Billion INR | 15.38% |
| 2009 FY | 5.18 Billion INR | 34.52% |
| 2008 FY | 3.85 Billion INR | -1.56% |
| 2007 FY | 3.91 Billion INR | 29.64% |
| 2006 FY | 3.02 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aarti Drugs Limited | 2.75 Billion INR | -266.652% |
| Albert David Limited | 6.01 Million INR | -167703.108% |
| Alembic Limited | 73.9 Million INR | -13560.399% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | -455.365% |
| Hikal Limited | 4.22 Billion INR | -138.738% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | 382.22 Million INR | -2541.151% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -1505.444% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -9287.936% |
| Bajaj HealthCare Limited | 650.34 Million INR | -1452.258% |
| Brooks Laboratories Limited | 3.56 Million INR | -283070.687% |
| Eris Lifesciences Limited | 6.54 Billion INR | -54.239% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -759.591% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -13258.522% |
| Wanbury Limited | 820 Million INR | -1131.102% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -2523658.75% |
| Alkem Laboratories Limited | 400 Million INR | -2423.759% |
| FDC Limited | 2.46 Million INR | -409268.816% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -6738.991% |
| Gufic Biosciences Limited | 1.53 Billion INR | -555.679% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -8943.623% |
| Innova Captab Limited | 2.1 Billion INR | -379.529% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ipca Laboratories Limited | 5.8 Billion INR | -73.929% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 68.125% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Lupin Limited | 1.55 Billion INR | -550.118% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -7459.502% |
| Medico Remedies Limited | 8.67 Million INR | -116309.536% |
| Morepen Laboratories Limited | 33.64 Million INR | -29909.022% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -619.487% |
| Orchid Pharma Limited | 1.2 Billion INR | -738.251% |
| Procter & Gamble Health Limited | 68.8 Million INR | -14573.016% |
| RPG Life Sciences Limited | -30.3 Million INR | 33416.947% |
| Sigachi Industries Limited | 265.79 Million INR | -3698.01% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -75802.519% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -4653.826% |
| Themis Medicare Limited | 267.74 Million INR | -3670.462% |
| Vaishali Pharma Limited | 35.98 Million INR | -27955.012% |
| Venus Remedies Limited | 386.8 Million INR | -2509.885% |
| Windlas Biotech Limited | 20.18 Million INR | -49924.95% |
| ZIM Laboratories Limited | 356 Million INR | -2735.636% |
| Sakar Healthcare Limited | 549.55 Million INR | -1736.964% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 52.714% |
| Divi's Laboratories Limited | 20 Million INR | -50375.175% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -36166.112% |
| Mankind Pharma Limited | 325.81 Million INR | -2998.395% |
| Sequent Scientific Limited | 1.42 Billion INR | -607.336% |
| Laurus Labs Limited | 7.98 Billion INR | -26.468% |
| Neuland Laboratories Limited | 449.2 Million INR | -2147.306% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -4170.319% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -565.5% |
| Zydus Lifesciences Limited | 251 Million INR | -3921.926% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -72172.587% |
| Wockhardt Limited | 8.91 Billion INR | -13.3% |
| Bal Pharma Limited | 363.82 Million INR | -2674.703% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -68.531% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -2736.305% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -109628.641% |
| Shilpa Medicare Limited | 5.6 Billion INR | -80.217% |
| Valiant Laboratories Limited | 750.89 Million INR | -1244.393% |
| Ajanta Pharma Limited | 235.2 Million INR | -4192.107% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -31208.486% |
| Granules India Limited | 689.71 Million INR | -1363.664% |
| Medicamen Biotech Limited | 12.55 Million INR | -80306.491% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 828240.689% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.116% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 37.063% |
| NATCO Pharma Limited | 53 Million INR | -18947.236% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -450.138% |
| Strides Pharma Science Limited | 6.71 Billion INR | -50.336% |
| Indoco Remedies Limited | 3.51 Billion INR | -187.011% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -9370.014% |